https://de.marketscreener.com/kurs/aktie/SCHOLAR-ROCK-HOLDING-CORP-43499888/news/Scholar-Rock-treibt-Antimyostatin-Programm-zur-Entwicklung-neuartiger-Therapien-fur-kardiometabolis-45044194/?utm_source=telegram&utm_medium=social&utm_campaign=share